| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 6, 2016The Medtronic Micra® TPS is the First Transcatheter Pacemaker Approved in the U.S.
DUBLIN - April 6, 2016 - Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval of the world's smallest pacemaker, the Medtronic Micra...
-
Mar 7, 2016FORWARD Clinical Study Designed to Confirm the Exceptional Results Achieved in the Evolut R CE Study
DUBLIN - March 7, 2016 - Medtronic plc (NYSE: MDT) today announced the first patients enrolled in the Evolut R FORWARD Clinical Study, a global, multi-center, single-arm, prospective study of up...
-
Mar 1, 2016Revenue of $6.9 Billion Grew 6% on a Comparable, Constant Currency Basis; 61% as Reported
DUBLIN - March 1, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2016, which ended January 29, 2016. Unless otherwise noted, all revenue...
-
Feb 21, 2016Now Offering Both 1.5 and 3 Tesla Indications for MR-Conditional ICMs, Pacemakers, ICDs and CRT-Ds
DUBLIN - February 22, 2016 - Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for the first and only cardiac resynchronization therapy defibrillators...
-
Feb 12, 2016The NICE guidance reviewed two sensor-augmented insulin pump therapy systems and recommends the MiniMed® Paradigm Veo(TM) system for managing glucose levels in people with Type 1 diabetes.1
DUBLIN - February 12, 2016 - Today, the United Kingdom's National Institute for Health and Care Excellence (NICE) has issued positive guidance for the use of Medtronic insulin pump systems...